Squar Milner Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-10,891
Closed -$1.07M 3
2020
Q2
$1.07M Buy
10,891
+2,389
+28% +$210K 0.61% 35
2020
Q1
$647K Buy
8,502
+666
+8% +$56.7K 0.39% 50
2019
Q4
$693K Sell
7,836
-3,328
-30% -$276K 0.35% 58
2019
Q3
$978K Buy
11,164
+4,965
+80% +$340K 0.5% 49
2019
Q2
$451K Buy
6,199
+320
+5% +$25.2K 0.3% 77
2019
Q1
$473K Hold
5,879
0.35% 65
2018
Q4
$542K Buy
5,879
+937
+19% +$82.4K 0.52% 38
2018
Q3
$467K Sell
4,942
-2,700
-35% -$256K 0.42% 55
2018
Q2
$708K Buy
7,642
+804
+12% +$78.5K 0.62% 33
2018
Q1
$647K Buy
6,838
+69
+1% +$7.58K 0.82% 33
2017
Q4
$828K Buy
+6,769
New +$638K 1% 23

Other funds holding ABBV

Squar Milner Financial Services's ABBV Position: Q3 2020 in Review

Squar Milner Financial Services sold out of AbbVie (ABBV) in Q3 2020, closing a stake of 10,891 shares — an estimated $1.07M sold.

Squar Milner Financial Services first reported a position in ABBV in Q4 2017 and held it in 11 quarters. The position peaked at $1.07M in Q2 2020. 2,367 funds tracked by Wall St. Rank hold ABBV as of Q3 2020.

  • Squar Milner Financial Services reported no remaining AbbVie position as of Q3 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 10,891 AbbVie shares in Q3 2020, an estimated $1.07M.
  • Squar Milner Financial Services first reported a position in AbbVie in Q4 2017 and held it in 11 quarters.
  • Squar Milner Financial Services's AbbVie position peaked at $1.07M in Q2 2020.
  • 2,367 funds tracked by Wall St. Rank held AbbVie as of Q3 2020.

Based on Squar Milner Financial Services's 13F filing for Q3 2020.